Abstract
The effectiveness of screening mammography in reducing mortality from breast cancer has been well documented in several randomized clinical trials. Mammographic signs of breast cancer cover a wide spectrum including the commonly encountered irregular spiculated masses, pleomorphic microcalcifications, as well as asymmetry and architectural distortion. There are certain mammographic signs that are subtle, and these account for a significant number of missed cancers. Such subtle signs include small developing densities or findings that are obscured by dense glandular tissue. The mammographic signs of breast cancer and the differential diagnosis are discussed in this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Venkatesan A, Chu P, Kerlikowske K, Sickles E, Smith-Bindman R. Positive predictive value of specific mammographic findings according to reader and patient variables. Radiology. 2009;250(3):648–57.
Gajdos C, Tartler PI, Bleiweiss IJ. Mammographic appearance of nonpalpable breast cancer reflects pathologic characteristics. Ann Surg. 2002;235(2):246–51.
Liberman L, Abramson AF, Squires FB, Glassman JR, Morris EA, Dershaw DD. The breast imaging reporting and data system: positive predictive value of mammographic features and final assessment categories. AJR Am J Roentgenol. 1998;171(1):35–40.
Sickles EA. Breast masses: mammographic evaluation. Radiology. 1989;173(2):297–303.
American College of Radiology. Breast imaging reporting and data system (BI-RADS). 4th ed. Reston: American College of Radiology; 2003.
Woods RW, Sisney GS, Salkowski LR, Shinki K, Lin Y, Burnside ES. The mammographic density of a mass is a significant predictor of breast cancer. Radiology. 2011;258(2):417–25.
Woods RW, Oliphant L, Shinki K, Page D, Shavlik J, Burnside E. Validation of results from knowledge discovery: mass density as a predictor of breast cancer. J Digit Imaging. 2010;23(5):554–61.
Tamaki K, Ishida T, Miyashita M, Amari M, Ohuchi N, Tamaki N, Sasano H. Correlation between mammographic findings and corresponding histopathology: potential predictors for biological characteristics of breast diseases. Cancer Sci. 2011;102(12):2179–85.
Thurfjell MG, Lindgren A, Thurfjell E. Nonpalpable breast cancer: mammographic appearance as predictor of histologic type. Radiology. 2002;222(1):165–70.
Reiff DB, Cooke J, Griffin M, Given-Wilson R. Ductal carcinoma in situ presenting as a stellate lesion on mammography. Clin Radiol. 1994;49:396–9.
Thurfjell E, Thurfjell MG, Lindgren A. Mammographic finding as predictor of survival in 1–9 mm invasive breast cancers. Worse prognosis for cases presenting as calcifications alone. Breast Cancer Res Treat. 2001;67(2):177–80.
Ikeda DM, Anderson I. Ductal carcinoma in situ: atypical mammographic appearances. Radiology. 1989;172:661–9.
Sekine K, et al. DCIS showing architectural distortion on screening mammogram – comparison of mammographic and pathological findings. Breast Cancer. 2007;14(3):281–4.
Lopez JK, Bassett LW. Invasive lobular carcinoma of the breast: spectrum of mammographic, US, and MR imaging findings. Radiographics. 2009;29:165–76.
Tabar L, Dean PB. Stellate lesions. In: Tabar L, Dean PB, editors. Teaching atlas of mammography. Second revised. New York: Georg Thieme Verlag; 1985. p. 87–136.
Kennedy M, Masterson AV, Kerin M, Flanagan F. Pathology and clinical relevance of radial scars: a review. J Clin Pathol. 2003;56(10):721–4.
Neilsen M, Christensen L, Anderson J. Radial scars in women with breast cancer. Cancer. 1987;59:1019–25.
Ciatto S, Morrone D, Catarzi S, et al. Radial scars of the breast: review of 38 consecutive mammographic diagnoses. Radiology. 1993;187:757–60.
King TA, Scharfenberg JC, Smetherman DH, et al. A better understanding of the term radial scar. Am J Surg. 2000;180(6):428–32.
Cohen MA, Sferlazza SJ. Role of sonography in evaluation of radial scars of the breast. AJR Am J Roentgenol. 2000;174:1075–8.
Shetty MK. Radial scars of the breast: sonographic findings. Ultrasound Q. 2002;18(3):203–7.
Finlay ME, Liston JE, Lunt LG, et al. Assessment of the role of ultrasound in the differentiation of radial scars and stellate carcinomas of the breast. Clin Radiol. 1994;49:52–5.
Shaheen R, Schimmelpenninck CA, Stoddart L, Raymond H, Slanetz PJ. Spectrum of diseases presenting as architectural distortion on mammography: multimodality radiologic imaging with pathologic correlation. Semin Ultrasound CT MR. 2011;32(4):351–62.
Taşkin F, Köseoğlu K, Unsal A, Erkuş M, Ozbaş S, Karaman C. Sclerosing adenosis of the breast: radiologic appearance and efficiency of core needle biopsy. Diagn Interv Radiol. 2011;17(4):311–6.
Günhan-Bilgen I, Memiş A, Ustün EE, Ozdemir N, Erhan Y. Sclerosing adenosis: mammographic and ultrasonographic findings with clinical and histopathological correlation. Eur J Radiol. 2002;44(3):232–8.
Hogge JP, Robinson RE, Magnant CM, Zuurbier RA. The mammographic spectrum of fat necrosis of the breast. Radiographics. 1995;15(6):1347–56.
DiPiro PJ, Meyer JE, Frenna TH, Denison CM. Seat belt injuries of the breast: findings on mammography and sonography. AJR Am J Roentgenol. 1995;164(2):317–20.
Demitri-Lewis A, Slaentz PJ, Eisneberg RL. Breast calcifications: the focal group. AJR Am J Roentgenol. 2012;198:W325–43.
Bird RE. Critical pathways in analyzing breast microcalcifications. Radiographics. 1995;15:928–34.
Stomper PC, Geradts J, Edge SB, Levine EG. Mammographic predictors of the presence and size of invasive carcinomas associated with malignant microcalcifications lesions without a mass. AJR Am J Roentgenol. 2003;181:1679–84.
Samardar P, Shaw de Paredes E, Grimes MM, Wilson JD. Focal asymmetric densities seen at mammography: US and pathologic correlation. Radiographics. 2002;22:19–33.
Sickles EA. The spectrum of breast asymmetries: imaging features, work-up, management. Radiol Clin North Am. 2007;45(5):765–71.
Sickles EA. Findings at mammographic screening on only one standard projection: outcomes analysis. Radiology. 1998;208(2):471–5.
Kopans DB, Swan CA, White G, et al. Asymmetric breast tissue. Radiology. 1989;171(3):639–43.
Leung JWT, Sickles EA. Developing asymmetry identified on mammography: correlation with imaging outcome and pathologic findings. AJR Am J Roentgenol. 2007;188(3):667–75.
Sickles EA. Mammographic features of 300 consecutive nonpalpable breast cancers. AJR Am J Roentgenol. 1986;146:661–3.
Shetty MK, Watson AB. Sonographic evaluation of focal asymmetric density of the breast. Ultrasound Q. 2002;18(2):115–21.
Youk JH, Kim E, Ko KH, et al. Asymmetric mammographic findings based on the fourth edition of BI-RADS: types, evaluation, and management. Radiographics. 2009;29(1):1–48.
Brenner RJ. Strategies in the evaluation of breast asymmetries. Appl Radiol. 1998;27:15–20.
Reed SD, Buist DS, Anderson ML, Bowles EJ, Fitzgibbons D, Seger D, Newton KM. Short-term (1–2 mo) hormone therapy cessation before mammography. Menopause. 2009;16(6):1125–31.
Buist DS, Anderson ML, Reed SD, Aiello Bowles EJ, Fitzgibbons ED, Gandara JC, Seger D, Newton KM. Short-term hormone therapy suspension and mammography recall: a randomized trial. Ann Intern Med. 2009;150(11):752–65.
Performance measures for 1,960,150 screening mammography examinations from 2002 to 2006 by age – based on BCSC data as of 2009 NCI-funded Breast Cancer Surveillance Consortium co-operative agreement (U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040). Downloaded from the Breast Cancer Surveillance Consortium Web site. http://breastscreening.cancer.gov/data/performance/screening/2009/perf_age.html.
Majid AS, Parades ES, Doherty RD, Sharma NR, Salvador X. Missed breast carcinoma: pitfalls and pearls. Radiographics. 2003;23:881–95.
Roberts-Klein S, Iuanow E, Slaentz PJ. Avoiding pitfalls in mammographic interpretation. Can Assoc Radiol J. 2011;62:50–9.
Ikeda DM, Birdwell RL, O’Shaughnessy KF, Brenner RJ, Sickles EA. Analysis of 172 subtle findings on prior normal mammograms in women with breast cancer detected at follow-up screening. Radiology. 2003;226:494–503.
Berlin L. Missed mammographic abnormalities, malpractice, and expert witnesses: does majority rule in the courtroom? [letter]. Radiology. 2003;229:288–9.
Harvey JA, Fajardo LL, Innis CA. Previous mammograms in patients with impalpable breast carcinoma: retrospective vs blinded interpretation. 1993 ARRS President’s Award. Am J Roentgenol. 1993;161:1167–72.
Destounis SV, DiNitto P, Logan-Young W, Bonaccio E, Zuley ML, Willison KM. Can computer-aided detection with double reading of screening mammograms help decrease the false-negative rate? Initial experience. Radiology. 2004;232(2):578–84.
Ikeda DM, Birdwell RL, O’Shaughnessy KF, Sickles EA, Brenner RJ. Computer-aided detection output on 172 subtle findings on normal mammograms previously obtained in women with breast cancer detected at follow-up screening mammography. Radiology. 2004;230(3):811–9.
Noble M, Bruening W, Uhl S, Schoelles K. Computer aided detection mammography for breast cancer screening: systematic review and meta-analysis. Arch Gynecol Obstet. 2009;279(6):881–90.
Giess CS, Frost EP, Birdwell RL. Difficulties and errors in diagnosis of breast neoplasms. Semin Ultrasound CT MR. 2012;33:288–99.
Brenner RJ. False-negative mammograms: medical, legal, and risk management implications. Radiol Clin North Am. 2000;38:741–57.
Bird RE, Wallace TW, Yankaskas BC. Analysis of cancers missed at screening mammography. Radiology. 1992;184:613–7.
Goergen SK, Evans J, Cohen GP, et al. Characteristics of breast carcinomas missed by screening radiologists. Radiology. 1997;204:131–5.
Wolfe JN. Mammography: ducts as a sole indicator of breast carcinoma. Radiology. 1967;89:206–10.
Huynh PT, Parellada JA, de Paredes ES, et al. Dilated duct pattern at mammography. Radiology. 1997;204:137–41.
Chang CB, Lvoff NM, Leung JW, et al. Solitary dilated duct identified at mammography: outcomes analysis. AJR Am J Roentgenol. 2010;194:378–82.
Crowe DJ, Helvie MA, Wilson TE, Crowe DJ. Breast infection. Mammographic and sonographic findings with clinical correlation. Invest Radiol. 1995;30(10):582–7.
Kwak JY, Kim EK, Chung SY, You JK, Oh KK, Lee YH, et al. Unilateral breast edema: spectrum of etiologies and imaging appearances. Yonsei Med J. 2005;46:1–7.
An YY, Kim SH, Cha ES, et al. Diffuse infiltrative lesion of the breast: clinical and radiologic features. Korean J Radiol. 2011;12(1):113–21.
Han BK, Choe YH, Park JM, Moon WK, Ko YH, Yang JH, et al. Granulomatous mastitis: mammographic and sonographic appearances. AJR Am J Roentgenol. 1999;173:317–20.
Levine PH, Steinhorn SC, Ries LG, Aron JL. Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program. J Natl Cancer Inst. 1985;74:291–7.
Chang S, Parker SL, Pham T, Buzdar AU, Hursting SD. Inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program of the National Cancer Institute, 1975–1992. Cancer. 1998;82:2366–72.
Hance KW, Anderson WF, Devesa SS, Young HA, Levine PH. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst. 2005;97:966–75.
Yang WT, Le-Petross HT, Macapinlac H, et al. Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings. Breast Cancer Res Treat. 2008;109(3):417–26.
Dershaw DD, Moore MP, Liberman L, et al. Inflammatory breast carcinoma: mammographic findings. Radiology. 1994;190:831–4.
Lee B, Tannenbaum N. Inflammatory carcinoma of the breast: a report of twenty-eight cases from the breast clinic of memorial hospital. Surg Gynecol Obstet. 1924;39:580–5.
Droulias CA, Sewell CW, McSweeney MB, et al. Inflammatory carcinoma of the breast: a correlation of clinical, radiologic and pathologic findings. Ann Surg. 1976;184:217–22.
Gunhan-Bilgen I, Ustun EE, Memis A. Inflammatory breast carcinoma: mammographic, ultrasonographic, clinical, and pathologic findings in 142 cases. Radiology. 2002;223:829–38.
Kushwaha AC, Whitman GJ, Stelling CB, et al. Primary inflammatory carcinoma of the breast: retrospective review of mammographic findings. AJR Am J Roentgenol. 2000;174:535–8.
Caumo F, Gaioni MB, Bonetti F, et al. Occult inflammatory breast cancer: review of clinical, mammographic, US and pathologic signs. Radiol Med (Torino). 2005;109:308–20.
Tardivon AA, Viala J, CorvellecRudelli A, et al. Mammographic patterns of inflammatory breast carcinoma: a retrospective study of 92 cases. Eur J Radiol. 1997;24:124–30.
Lee KW, Chung SY, Yang I, et al. Inflammatory breast cancer: imaging findings. Clin Imaging. 2005;29(22–250):1014–24.
Shetty MK, Carpenter WS. Sonographic evaluation of isolated abnormal axillary lymph nodes identified on mammograms. J Ultrasound Med. 2004;23(1):63–71.
Given-Wilson RM, Murray ME. The clinical importance of axillary lymphadenopathy detected on screening mammography. Clin Radiol. 1997;52:458–61.
Bergvist L, Frodis E, Hedborg-Mellander C, Hansen J. Management of accidentally found pathological lymph nodes on routine screening mammography. Eur J Surg Oncol. 1996;22:250–3.
Lee LH, Giurescu ME, Philpotts LE, Horvath LJ, Tocino I. Clinical importance of unilaterally enlarging lymph nodes on otherwise normal mammograms. Radiology. 1997;203:329–34.
Görkem SB, O’Connell AM. Abnormal axillary lymph nodes on negative mammograms: causes other than breast cancer. Diagn Interv Radiol. 2012;18(5):473–9.
Walsh R, Kornuguth PJ, Soo MS, Bentley R, Delong DM. Axillary lymph nodes: mammographic, pathologic and clinical correlation. AJR Am J Roentgenol. 1997;168:33–8.
Rahbar H, Partridge SC, Javid SH, Lehman CD. Imaging axillary lymph nodes in patients with newly diagnosed breast cancer. Curr Probl Diagn Radiol. 2012;41(5):149–58.
Morris EA, Schwartz LH, Dershaw DD, Van Zee KJ, Abramson AF, Liberman L. MR imaging of the breast in patients with occult primary breast carcinoma. Radiology. 1997;205:437–40.
Tilanus-Linthorst MM, Obdeijn AI, Bontenbal M, Oudkerk M. MRI in patients with axillary metastases of occult breast carcinoma. Breast Cancer Res Treat. 1997;44:179–82.
Obdeijn IM, Brouwers-Kuyper EM, Tilanus-Linthorst MM, Wiggers T, Oudkerk M. MR imaging-guided sonography followed by fine-needle aspiration cytology in occult carcinoma of the breast. AJR Am J Roentgenol. 2000;174:1079–84.
Lin NU, Vanderplas A, Hughes ME, et al. Clinicopathological features and sites of recurrence according to breast cancer subtype in the National Comprehensive Cancer Network (NCCN). J Clin Oncol. 2009;27(15s):Abstr 543.
Yang WT, Dryden M, Broglio K, et al. Mammographic features of triple receptor negative primary breast cancers in young premenopausal women. Breast Cancer Res Treat. 2008;111:405–10.
Wang Y, Ikeda DM, Narasimhan B, et al. Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 over expression. Radiology. 2008;246:367–75.
Dogan BE, Gonzalez-Angulo AM, Gilcrease M, et al. Multimodality imaging of triple receptor-negative tumors with mammography, ultrasound, and MRI. AJR Am J Roentgenol. 2010;194:1160–6.
Kojima Y, Tsunoda H. Mammography and ultrasound feature of triple-negative breast cancer. Breast Cancer. 2011;18:146–51.
Kojima Y, Tsunoda H, Honda S, Kikuchi M, Kawauchi N, Yoshida A, Yagata H, Yamauchi H, Suzuki K. Radiographic features for triple negative ductal carcinoma in situ of the breast. Breast Cancer. 2011;18(3):213–20.
Krecke KN, Gisvold JJ. Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients. AJR Am J Roentgenol. 1993;161(5):957–60.
Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology. 2004;233(3):830–49.
Selinko VL, Middleton LP, Dempsey PJ. Role of sonography in diagnosing and staging invasive lobular carcinoma. J Clin Ultrasound. 2004;32(7):323–32.
Hilleren DJ, Andersson IT, Lindholm K, Linnell FS. Invasive lobular carcinoma: mammographic findings in a 10-year experience. Radiology. 1991;178(1):149–54.
Le Gal M, Ollivier L, Asselain B, et al. Mammographic features of 455 invasive lobular carcinomas. Radiology. 1992;185(3):705–8.
Butler RS, Venta LA, Wiley EL, Ellis RL, Dempsey PJ, Rubin E. Sonographic evaluation of infiltrating lobular carcinoma. AJR Am J Roentgenol. 1999;172(2):325–30.
Paramagul CP, Helvie MA, Adler DD. Invasive lobular carcinoma: sonographic appearance and role of sonography in improving diagnostic sensitivity. Radiology. 1995;195(1):231–4.
Evans WP, Warren Burhenne LJ, Laurie L, O’Shaughnessy KF, Castellino RA. Invasive lobular carcinoma of the breast: mammographic characteristics and computer- computer-aided detection. Radiology. 2002;225(1):182–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Shetty, M.K. (2015). Mammographic Signs of Breast Cancer. In: Shetty, M. (eds) Breast Cancer Screening and Diagnosis. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1267-4_5
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1267-4_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1266-7
Online ISBN: 978-1-4939-1267-4
eBook Packages: MedicineMedicine (R0)